FDA Import Refusal AEK-9170291-8/20003/1 — Exemed Pharmaceuticals

Exemed Pharmaceuticals — FEI 3005822020

The FDA refused shipment AEK-9170291-8/20003/1 from Exemed Pharmaceuticals (India) on Jan 2, 2026. The refused product falls under Drugs and Biologics — SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Jan 2, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61NDY78 SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.